U.S. markets close in 4 hours 48 minutes
  • S&P 500

    4,153.27
    +18.33 (+0.44%)
     
  • Dow 30

    34,024.10
    +202.80 (+0.60%)
     
  • Nasdaq

    13,833.43
    +47.16 (+0.34%)
     
  • Russell 2000

    2,221.97
    +33.76 (+1.54%)
     
  • Crude Oil

    62.21
    -0.46 (-0.73%)
     
  • Gold

    1,790.50
    +12.10 (+0.68%)
     
  • Silver

    26.47
    +0.62 (+2.42%)
     
  • EUR/USD

    1.2034
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.5820
    +0.0200 (+1.28%)
     
  • GBP/USD

    1.3932
    -0.0004 (-0.03%)
     
  • USD/JPY

    108.1360
    +0.0660 (+0.06%)
     
  • BTC-USD

    56,212.10
    -82.45 (-0.15%)
     
  • CMC Crypto 200

    1,291.99
    +29.03 (+2.30%)
     
  • FTSE 100

    6,908.53
    +48.66 (+0.71%)
     
  • Nikkei 225

    28,508.55
    -591.83 (-2.03%)
     

Cormedix's Earnings: A Preview

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Cormedix (AMEX: CRMD) unveils its next round of earnings this Monday, August 10. Here is Benzinga's everything-that-matters guide for the earnings announcement.

Earnings and Revenue

Cormedix EPS is expected to be around $-0.14, according to sell-side analysts. Sales will likely be near $90.00 thousand. In the same quarter last year, Cormedix reported a loss per share of $-0.03 on sales of $35.27 thousand. If the company were to report in-line earnings when it publishes results Monday, quarterly profit would be down 366.67%. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

EPS Estimate

-0.23

-0.24

-0.25

-0.21

EPS Actual

-0.21

-0.21

-0.22

-0.03

Revenue Estimate

170.00 K

90.00 K

190.00 K

130.00 K

Revenue Actual

74.05 K

24.78 K

59.53 K

35.27 K

Stock Performance

Over the past 52-week period, shares of Cormedix have declined 49.14%.

View more earnings on CRMD

When looking at these results, it would make sense for shareholders to feel unsatisfied with these results.

Don't be surprised to see the stock move on comments made during its conference call. Cormedix is scheduled to hold the call at 16:30:00 ET and can be accessed here: http://public.viavid.com/player/index.php?id=141024

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.